How M.D. was paid
$1.9M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Options | Other | Total |
|---|---|---|---|---|---|
| Phillip Frost, M.D.Chief Executive Officer | $960,000 | $480,000 | $400,000 | $14,000 | $1,854,000 |
| Jane H. Hsiao, Ph.D.Chief Technical Officer | $900,000 | $450,000 | $400,000 | $14,000 | $1,764,000 |
| Elias A. Zerhouni, M.D.President | $900,000 | $450,000 | $400,000 | $14,000 | $1,764,000 |
| Steven D. RubinExecutive Vice President-Administration | $810,000 | $400,000 | $350,000 | $14,000 | $1,574,000 |
| Adam LogalSenior Vice President and Chief Financial Officer | $700,000 | $475,000 | $350,000 | $14,000 | $1,539,000 |
What changed and why
- $1.9M$1,854,000 was CEO total compensation in 2025, down from $2,163,800 in 2024.
- $400K$400,000 was the CEO’s 2025 option-award grant-date fair value; no restricted stock award was reported.
- $960K$960,000 salary and $480,000 bonus comprised the CEO’s 2025 cash compensation.
- 500,000 options were granted to each of the CEO, CTO, and President, vesting in four annual tranches.
- 98%98% of votes cast supported named executive officer compensation at the 2025 annual meeting.
- $1.1M$1.1 million was the approximate value of accelerated option vesting for the CEO upon a December 31, 2025 change in control.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.